NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹15.94
0.24%
NAV as on 21 Nov 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 21 Nov 24, 12:00 AM
very high risk
sector healthcare
equity
49.76%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
57.82%p.a.
Since Inception
About HDFC Pharma and Healthcare Fund Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the HDFC Pharma and Healthcare Fund Growth scheme from HDFC Asset Management Co Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Oct 2023, HDFC Pharma and Healthcare Fund Growth is Sector - Healthcare fund of its category with 1,382.6 Cr fund under management as on Nov 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
- HDFC Pharma and Healthcare Fund Growth delivered 49.8% annual returns during the last year. It has delivered 57.8% average annual returns since the fund was launched.
- HDFC Pharma and Healthcare Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd
14.02%
Cipla Ltd
8.17%
Divi's Laboratories Ltd
7.91%
Lupin Ltd
6.25%
Ipca Laboratories Ltd
4.08%
Gland Pharma Ltd
4.00%
Aurobindo Pharma Ltd
3.44%
Piramal Pharma Ltd
3.41%
Dr Reddy's Laboratories Ltd
3.32%
Eris Lifesciences Ltd Registered Shs
3.27%
Fund Managers
- Dhruv Muchhal (Oct 2023 - Present)
- Nikhil Mathur (Oct 2023 - Present)
Key Information
View Scheme Document
HDFC Pharma and Healthcare Fund Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on HDFC Pharma and Healthcare Fund Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in HDFC Pharma and Healthcare Fund Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in HDFC Pharma and Healthcare Fund Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
Nippon India Pharma Fund - Growth
very high risk | equity
19.5%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
very high risk | equity
24.4%
SBI Healthcare Opportunities Fund Growth
very high risk | equity
23.2%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved